Established in 2010, the Anagenix is a New Zealand nutraceutical companies that are responding innovatively to the global need for natural health solutions. Creation of the Anagenix was inspired by the need for a commercialisation link between ground-breaking New Zealand science and the world market. New Zealand has a strong heritage of discovery and development in the natural bioactive arena, led by government and private research organisations that focus on uses for New Zealand’s superior horticultural and marine products. Anagenix work with crown research institutions in New Zealand to bring the best of New Zealand’s horticulture to the world of nutraceuticals. Our Science team collaborates with various universities and research institutions to run In-Vitro, In-Vivo and Clinical Studies on New Zealand plants and fruits. The Science, coupled with Anagenix’s proprietary method of processing the NZ ingredients ensure that our products have high bioavailability and are able to stand-up to the rigour of scientific testing. Our products Actazin and Livaux promote bowel regularity and microbiome balance in digestive health, BerriQi promote lung health (especially targeting air pollution) and we have various other products in the pipeline for blood glucose management and protein digestion. Anagenix is actively building distribution networks in the USA, Canada, Australia, Asia and Europe. In 2014 it was approved as a Focus 500 company by New Zealand Trade & Enterprise. It is also ranked #53 on Deloitte’s Asia Pacific Technology Fast 500 for 2014.